USA President Donald Trump Speaks On First Human Trial Of Coronavirus (COVID-19)

USA President Donald Trump Speaks On First Human Trial Of Coronavirus (COVID-19)
Experimental COVID-19 Vaccine Test Begins as U.S. Volunteer Receives First Shot
U.S. researchers gave the first shot to the first person in a test of an experimental coronavirus vaccine Monday — leading off a worldwide hunt for protection even as the pandemic surges.

(SEATTLE) — U.S. researchers gave the first shot to the first person in a test of an experimental coronavirus vaccine Monday — leading off a worldwide hunt for protection even as the pandemic surges.

With a careful jab in a healthy volunteer’s arm, scientists at the Kaiser Permanente Washington Research Institute in Seattle begin an anxiously awaited first-stage study of a potential COVID-19 vaccine developed in record time after the new virus exploded from China and fanned across the globe.

Read more: Jorge Jesus Flamengo Manager Tested Positive For COVID-19

“We’re team coronavirus now,” Kaiser Permanente study leader Dr. Lisa Jackson said on the eve of the experiment. “Everyone wants to do what they can in this emergency.”

The Associated Press observed as the study’s first participant, an operations manager at a small tech company, received the injection inside an exam room. Several others were next in line for a test that will ultimately give 45 volunteers two doses, a month apart.

See what Donald Trump said about Coronavirus (COVID-19) Vaccine

 

“We all feel so helpless. This is an amazing opportunity for me to do something,” said Jennifer Haller, 43, of Seattle. She’s the mother of two teenagers and “they think it’s cool” that she’s taking part in the study.

Monday’s milestone marked just the beginning of a series of studies in people needed to prove whether the shots are safe and could work. Even if the research goes well, a vaccine wouldn’t be available for widespread use for 12 to 18 months, said Dr. Anthony Fauci of the U.S. National Institutes of Health. That’s still important if the virus becomes a long-term threat.

This vaccine candidate, code-named mRNA-1273, was developed by the NIH and Massachusetts-based biotechnology company Moderna Inc. There’s no chance participants could get infected from the shots because they don’t contain the coronavirus itself.

It’s not the only potential vaccine in the pipeline. Dozens of research groups around the world are racing to create a vaccine against COVID-19. Another candidate, made by Inovio Pharmaceuticals, is expected to begin its own safety study — in the U.S., China and South Korea — next month.

The Seattle experiment got underway days after the World Health Organization declared the new virus outbreak a pandemic because of its rapid global spread, infecting more than 169,000 people and killing more than 6,500.

COVID-19 has upended the world’s social and economic fabric since China first identified the virus in January, with regions shuttering schools and businesses, restricting travel, canceling entertainment and sporting events, and encouraging people to stay away from each other.

Starting what scientists call a first-in-humans study is a momentous occasion for scientists, but Jackson described her team’s mood as “subdued.” They’ve been working round-the-clock readying the research in a part of the U.S. struck early and hard by the virus.

Still, “going from not even knowing that this virus was out there … to have any vaccine” in testing in about two months is unprecedented, Jackson told the AP.

Some of the study’s carefully chosen healthy volunteers, ages 18 to 55, will get higher dosages than others to test how strong the inoculations should be. Scientists will check for any side effects and draw blood samples to test if the vaccine is revving up the immune system, looking for encouraging clues like the NIH earlier found in vaccinated mice.

“We don’t know whether this vaccine will induce an immune response, or whether it will be safe. That’s why we’re doing a trial,” Jackson stressed. “It’s not at the stage where it would be possible or prudent to give it to the general population.”

Most of the vaccine research under way globally targets a protein aptly named “spike” that studs the surface of the new coronavirus and lets it invade human cells. Block that protein and people won’t get infected.

Researchers at the NIH copied the section of the virus’ genetic code that contains the instructions for cells to create the spike protein. Moderna encased that “messenger RNA” into a vaccine.

The idea: The body will become a mini-factory, producing some harmless spike protein. When the immune system spots the foreign protein, it will make antibodies to attack — and be primed to react quickly if the person later encounters the real virus. That’s a much faster way of producing a vaccine than the traditional approach of growing virus in the lab and preparing shots from either killed or weakened versions of it.

But because vaccines are given to millions of healthy people, it takes time to test them in large enough numbers to spot an uncommon side effect, cautioned Dr. Nelson Michael of the Walter Reed Army Institute of Research, which is developing a different vaccine candidate.

“The science can go very quickly but, first, do no harm, right?” he told reporters last week.

The Seattle research institute is part of a government network of centers that test all kinds of vaccines, and was chosen for the coronavirus vaccine study before COVID-19 began spreading widely in Washington state.

Kaiser Permanente screened dozens of people, looking for those who have no chronic health problems and aren’t currently sick. Researchers aren’t checking whether would-be volunteers already had a mild case of COVID-19 before deciding if they’re eligible. If some did, scientists will be able to tell by the number of antibodies in their pre-vaccination blood test and account for that, Jackson said. Participants will be paid $100 for each clinic visit in the study.

Likeshare button

yout 300x87 1

👉 Open a free USA bank account from any country in the world and perform Online transactions

Copyright Warning!

We work really hard and put a lot of effort and resources into our content, providing our readers with plagiarism-free articles, original and high-quality texts. Contents on this website may not be copied, republished, reproduced, redistributed either in whole or in part without due permission or acknowledgement. Proper acknowledgement include, but not limited to (a) Proper referencing in the case of usage in research, magazine, brochure, or academic purposes, (b)"FAIR USE" in the case of re-publication on online media. About possible consequences you can read here: What are the consequences of copyright infringement? In an effort to protect our intellectual properties, we may report your website to Google without prior notice and your website be removed from search engines and you may receive a strike. All contents are protected by the Digital Millennium Copyright Act 1996 (DMCA).

28 thoughts on “USA President Donald Trump Speaks On First Human Trial Of Coronavirus (COVID-19)

  1. Long time supporter, and thought I’d drop
    a comment.

    Your wordpress site is very sleek – hope you don’t mind me asking what theme you’re
    using? (and don’t mind if I steal it? :P)

    I just launched my site –also built in wordpress like yours– but the theme slows (!) the site down quite a bit.

    In case you have a minute, you can find it by searching for “royal cbd” on Google (would appreciate any feedback) – it’s still in the works.

    Keep up the good work– and hope you all take care of yourself during the
    coronavirus scare!

  2. I really like what you guys are usually up too. This type of clever work and
    exposure! Keep up the excellent works guys I’ve incorporated you guys to our blogroll.

  3. Greetings from Colorado! I’m bored at work so I decided to check out your website on my iphone during lunch break.
    I really like the information you present here and
    can’t wait to take a look when I get home. I’m surprised at how fast your
    blog loaded on my phone .. I’m not even using WIFI, just 3G ..
    Anyhow, fantastic site!

  4. Hello my family member! I want to say that this article is amazing, great written and come
    with almost all significant infos. I’d like to see more posts
    like this .

  5. I like what you guys are up too. Such clever work and exposure!
    Keep up the excellent works guys I’ve you guys to my personal
    blogroll.

  6. Hurrah! Finally I got a blog from where I be able to in fact get
    helpful facts regarding my study and knowledge.

  7. Hello there! I know this is somewhat off topic but I was wondering which blog platform are you
    using for this site? I’m getting tired of WordPress because I’ve had
    issues with hackers and I’m looking at options for another platform.

    I would be great if you could point me in the direction of a good platform.

    1. Actually this blog platform is on WordPress. WordPress is the best Content Management system.

      I will advise you to always use it and use security plugins to stop hackers.

  8. Hello to all, how is everything, I think every one is getting
    more from this site, and your views are fastidious designed for new visitors.

  9. Howdy! This is my first comment here so I just wanted to give a quick shout out and tell
    you I genuinely enjoy reading your blog posts.
    Can you suggest any other blogs/websites/forums that deal with the same subjects?

    Appreciate it!

  10. Nice post. I was checking constantly this blog and
    I’m impressed! Very useful info particularly the last part :
    ) I care for such info much. I was looking for this particular information for a long time.
    Thank you and best of luck.

  11. Remarkable issues here. I’m very glad to peer your article.
    Thank you so much and I’m having a look forward to contact
    you. Will you please drop me a mail?

  12. I’ve been browsing online more than three hours today, yet
    I never found any interesting article like yours.
    It is pretty worth enough for me. In my view, if all website
    owners and bloggers made good content as
    you did, the internet will be a lot more useful than ever before.

  13. Thank you a lot for providing individuals with such a pleasant possiblity to read from this website. It’s always very awesome and full of amusement for me and my office acquaintances to visit your site a minimum of 3 times in 7 days to see the latest stuff you have got. And indeed, we’re always fulfilled concerning the astounding points served by you. Some 1 areas in this posting are truly the best I’ve had.

Leave a Reply

Your email address will not be published. Required fields are marked *

WhatsApp Us
1
Need help?
Hello!! How can we help you?